[1]
H. Hama_Salim and M. Babakir-Mina, “Immunological Impact of Calprotectin and Interleukin-34 in Immunocompromised Patients with Chronic Cytomegalovirus Infection”, ARO, vol. 14, no. 1, pp. 129–136, Apr. 2026.